Precision Medicine in Action: New Model May Predict If Cutaneous Leishmaniasis Patients Will Respond to Meglumine Antimoniate
Researchers have discovered a way to predict whether patients with cutaneous leishmaniasis will respond to meglumine antimoniate, potentially saving patients from months of expensive, ineffective and toxic medication.